Dr. Kaleb Tanner Veit, DO

Dr. Veit practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Veit's NPI, 1003178443, was assigned on June 12, 2012. Dr. Veit holds Iowa license DO-05991.

Dr. Veit's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Veit also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Veit's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Veit is also affiliated with University of Iowa Health Care Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Veit to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Veit practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Veit's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Veit is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Veit is licensed in Iowa.

CMS data shows 862 Medicare services from Dr. Veit across 13 procedure codes in 2024, for 382 Medicare patients. Medicare paid $37,748 for them.

CMS counts 382 Medicare patients who saw Dr. Veit in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Veit's median patient age at 69, with 51% women.

In 2024, Dr. Veit wrote 161 Medicare Part D claims for 41 patients. 54% of them were for generic drugs. CMS names the drug for 75 of them, across 4 drugs with 11 or more claims each, at $24,452 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

Dr. Veit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Veit as offering telehealth.

Dmand AI links 2 papers to Dr. Veit, published from 2024 to 2025. Dr. Veit's most frequent co-authors are Umar Farooq, MD, Eric Yu Mou, MD and Ruxana T. Sadikot.

CMS Open Payments shows 16 general payments to Dr. Veit from 5 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Melinta Therapeutics, Inc. paid the most, $121.